Literature DB >> 9888029

Outpatient parenteral antimicrobial therapy for osteomyelitis.

A D Tice1.   

Abstract

OPAT for osteomyelitis is effective, safe, and well-established. There are particular considerations with osteomyelitis, however, that relate to patient selection and the plans of therapy. Orthopedic infections may impose physical considerations that need to be considered. Concomitant medical problems, such as diabetes, must be considered and may be good reasons for hospital care aside from the infection. Further investigations of treatment of osteomyelitis are clearly needed, with OPAT patients being good subjects to study.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9888029     DOI: 10.1016/s0891-5520(05)70027-1

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  8 in total

1.  It's Not Just the Hospital Anymore.

Authors:  Donald M. Poretz
Journal:  Curr Infect Dis Rep       Date:  2003-08       Impact factor: 3.725

Review 2.  Ambulatory use of parenteral antibacterials: contemporary perspectives.

Authors:  J E Leggett
Journal:  Drugs       Date:  2000       Impact factor: 9.546

3.  Long Bone Osteomyelitis.

Authors:  Luca Lazzarini; Fausto De Lalla; Jon T. Mader
Journal:  Curr Infect Dis Rep       Date:  2002-10       Impact factor: 3.725

4.  Outpatient parenteral antimicrobial therapy practices among adult infectious disease physicians.

Authors:  Michael A Lane; Jonas Marschall; Susan E Beekmann; Philip M Polgreen; Ritu Banerjee; Adam L Hersh; Hilary M Babcock
Journal:  Infect Control Hosp Epidemiol       Date:  2014-05-09       Impact factor: 3.254

5.  [Diagnosis and follow-up management of postoperative bacterial osteitis].

Authors:  U Flückiger; W Zimmerli
Journal:  Orthopade       Date:  2004-04       Impact factor: 1.087

6.  The musculoskeletal effects of diabetes mellitus.

Authors:  Lawrence H Wyatt; Randy J Ferrance
Journal:  J Can Chiropr Assoc       Date:  2006-03

7.  Cost-Effectiveness Study of One-Stage Treatment of Chronic Osteomyelitis with Bioactive Glass S53P4.

Authors:  Jan Geurts; Tom van Vugt; Eline Thijssen; Jacobus J Arts
Journal:  Materials (Basel)       Date:  2019-09-30       Impact factor: 3.623

8.  Outpatient parenteral antibiotic therapy with daptomycin: insights from a patient registry.

Authors:  W J Martone; K C Lindfield; D E Katz
Journal:  Int J Clin Pract       Date:  2008-08       Impact factor: 2.503

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.